AndroScience Corporation Awarded a $3.8 Million, 3-Year Milestone-Driven, Cooperative Translational Research Grant from the National Institutes of Health (NIH) to Develop an Oral Treatment for Spinal Bulbar Muscular Atrophy (Kennedy's Disease)
1/25/2011 7:15:15 AM
More...
|
AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne
3/9/2009 9:33:25 AM
More...
|
AndroScience Corporation Enters Clinical Stage
2/13/2007 2:41:39 PM
More...
|